During the past decade, Berner Augenklinik am Lindenhofspital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Berner Augenklinik am Lindenhofspital" #1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "medignition AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Berner Augenklinik am Lindenhofspital" are "Neovascular Age-Related Macular Degeneration" (1 trials), "Retinal Detachment" (1 trials) and "Wet Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Berner Augenklinik am Lindenhofspital" in a lesser frequency.

Most popular intervention types in "Berner Augenklinik am Lindenhofspital" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (1 trials), "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials), "Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)" (1 trials), "Brolucizumab" (1 trials) and "ILM (inner limiting membrane) peeling" (1 trials). Other intervention names were less common.

The vast majority of trials in "Berner Augenklinik am Lindenhofspital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Berner Augenklinik am Lindenhofspital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were undefined completed trials in Berner Augenklinik am Lindenhofspital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Berner Augenklinik am Lindenhofspital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".